Product Description
Product Name: Docetax 80 mg Injection
Active Ingredient: Docetaxel
Strength: 80 mg
Form: Concentrate for Solution for Intravenous Infusion
Category: Anticancer / Taxane Chemotherapy Agent
Indication: Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Head and Neck Cancers
Docetax 80 mg Injection contains Docetaxel, a taxane-class chemotherapeutic agent used in the treatment of various solid tumors. It works by inhibiting cell division through the stabilization of microtubules, ultimately leading to cancer cell death.
Therapeutic Indications:
Breast cancer (locally advanced or metastatic)
Non-small cell lung cancer (NSCLC)
Hormone-refractory metastatic prostate cancer
Head and neck cancers, including squamous cell carcinoma
Key Features:
Administered via intravenous infusion under medical supervision
Often used in combination with other chemotherapeutic agents
Provides broad-spectrum activity against a range of solid tumors
To be administered by a qualified healthcare professional in an oncology setting. Pre-medication with corticosteroids is often required to reduce the risk of hypersensitivity reactions and fluid retention. Regular monitoring of blood counts and liver function is essential during treatment.
